FAS Wealth Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.7K | Sell |
804
-3,555
| -82% | -$295K | ﹤0.01% | 353 |
|
|
2025
Q1 | $354K | Hold |
4,359
| – | – | 0.03% | 244 |
|
|
2024
Q4 | $393K | Hold |
4,359
| – | – | 0.03% | 232 |
|
|
2024
Q3 | $431K | Sell |
4,359
-70
| -2% | -$6.92K | 0.03% | 224 |
|
|
2024
Q2 | $411K | Hold |
4,429
| – | – | 0.04% | 224 |
|
|
2024
Q1 | $420K | Hold |
4,429
| – | – | 0.04% | 222 |
|
|
2023
Q4 | $395K | Buy |
4,429
+2,540
| +134% | +$227K | 0.04% | 221 |
|
|
2023
Q3 | $138K | Hold |
1,889
| – | – | 0.01% | 285 |
|
|
2023
Q2 | $157K | Hold |
1,889
| – | – | 0.02% | 265 |
|
|
2023
Q1 | $144K | Buy |
1,889
+134
| +8% | +$10.2K | 0.02% | 294 |
|
|
2022
Q4 | $146K | Buy |
1,755
+995
| +131% | +$82.6K | 0.02% | 287 |
|
|
2022
Q3 | $60K | Buy |
760
+126
| +20% | +$9.95K | 0.01% | 313 |
|
|
2022
Q2 | $47K | Hold |
634
| – | – | ﹤0.01% | 324 |
|
|
2022
Q1 | $57K | Buy |
634
+44
| +7% | +$3.96K | 0.01% | 322 |
|
|
2021
Q4 | $66K | Hold |
590
| – | – | 0.01% | 328 |
|
|
2021
Q3 | $74K | Hold |
590
| – | – | 0.01% | 322 |
|
|
2021
Q2 | $80K | Sell |
590
-350
| -37% | -$47.5K | 0.01% | 306 |
|
|
2021
Q1 | $128K | Buy |
940
+90
| +11% | +$12.3K | 0.01% | 271 |
|
|
2020
Q4 | $120K | Hold |
850
| – | – | 0.01% | 261 |
|
|
2020
Q3 | $95K | Hold |
850
| – | – | 0.01% | 252 |
|
|
2020
Q2 | $95K | Hold |
850
| – | – | 0.01% | 239 |
|
|
2020
Q1 | $66K | Buy |
+850
| New | +$66K | 0.01% | 238 |
|